These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102. The wide spectrum of steatohepatitis: a report of four cases and a review of the literature. Lonardo A; Bagni A; Tarugi P; Loria P Eur J Gastroenterol Hepatol; 2004 Oct; 16(10):1043-50. PubMed ID: 15371930 [TBL] [Abstract][Full Text] [Related]
103. Nonalcoholic steatohepatitis masquerading as autoimmune hepatitis. Tajiri K; Takenawa H; Yamaoka K; Yamane M; Marumo F; Sato C J Clin Gastroenterol; 1997 Oct; 25(3):538-40. PubMed ID: 9412973 [TBL] [Abstract][Full Text] [Related]
104. Nonalcoholic steatohepatitis--a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Cortez-Pinto H; Baptista A; Camilo ME; De Moura MC Dig Dis Sci; 2003 Oct; 48(10):1909-13. PubMed ID: 14627331 [TBL] [Abstract][Full Text] [Related]
105. Nonalcoholic steatohepatitis and cirrhosis with Mallory's hyalin with ultrastructural study of one case. Itoh S; Matsuo S; Ichinoe A; Yamaba Y; Miyazawa M Dig Dis Sci; 1982 Apr; 27(4):341-6. PubMed ID: 6175490 [TBL] [Abstract][Full Text] [Related]
108. [Epidemiology and natural history of primary nonalcoholic fatty liver disease]. Moreno-Sánchez D Gastroenterol Hepatol; 2006 Apr; 29(4):244-54. PubMed ID: 16584696 [TBL] [Abstract][Full Text] [Related]
109. Another animal model for nonalcoholic steatohepatitis: how close to the human condition? Nanji AA Am J Clin Nutr; 2004 Mar; 79(3):350-1. PubMed ID: 14985206 [No Abstract] [Full Text] [Related]
111. Importance of iron and iron metabolism in nonalcoholic fatty liver disease. Baptista-Gonzalez H; Chavez-Tapia NC; Zamora-Valdés D; Uribe M; Mendez-Sanchez N Mini Rev Med Chem; 2008 Feb; 8(2):171-4. PubMed ID: 18289100 [TBL] [Abstract][Full Text] [Related]
112. Fatty liver persisting for up to 33 years. A follow-up of the inversen-roholm liver biopsy material. Hilden M; Juhl E; Thomsen AC; Christoffersen P Acta Med Scand; 1973 Dec; 194(6):485-9. PubMed ID: 4773448 [No Abstract] [Full Text] [Related]
113. Cryptogenic cirrhosis: what are we missing? Caldwell S Curr Gastroenterol Rep; 2010 Feb; 12(1):40-8. PubMed ID: 20425483 [TBL] [Abstract][Full Text] [Related]
114. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Brunt EM Semin Diagn Pathol; 2005 Nov; 22(4):330-8. PubMed ID: 16939061 [TBL] [Abstract][Full Text] [Related]
115. [Pathogenesis of fatty liver and cirrhosis. II. Histopathological approach]. Hartroft WS; Porta EA Arch Biol Med Exp; 1969; 3(Suppl 3):189-97. PubMed ID: 5409440 [No Abstract] [Full Text] [Related]
117. [Pathogenesis of fatty liver and cirrhosis. I. Biochemical approach]. Lieber CS Arch Biol Med Exp; 1969; 3(Suppl 3):179-89. PubMed ID: 5409366 [No Abstract] [Full Text] [Related]
118. Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease. Ryan MC; Wilson AM; Slavin J; Best JD; Jenkins AJ; Desmond PV Diabetes Care; 2005 May; 28(5):1222-4. PubMed ID: 15855597 [No Abstract] [Full Text] [Related]
119. Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management. Yan E; Durazo F; Tong M; Hong K Nutr Rev; 2007 Aug; 65(8 Pt 1):376-84. PubMed ID: 17867371 [TBL] [Abstract][Full Text] [Related]